GLOFIL-125 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Glofil-125, and when can generic versions of Glofil-125 launch?
Glofil-125 is a drug marketed by Isotex and is included in one NDA.
The generic ingredient in GLOFIL-125 is iothalamate sodium i-125. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the iothalamate sodium i-125 profile page.
Summary for GLOFIL-125
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 6 |
| Clinical Trials: | 1 |
| Patent Applications: | 4 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in GLOFIL-125? | GLOFIL-125 excipients list |
| DailyMed Link: | GLOFIL-125 at DailyMed |
Recent Clinical Trials for GLOFIL-125
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Colorado, Denver | Phase 4 |
Pharmacology for GLOFIL-125
| Drug Class | Radioactive Diagnostic Agent |
| Mechanism of Action | Radiopharmaceutical Activity |
US Patents and Regulatory Information for GLOFIL-125
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Isotex | GLOFIL-125 | iothalamate sodium i-125 | INJECTABLE;INJECTION | 017279-001 | Approved Prior to Jan 1, 1982 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
